SCHEMBL15980407

SCHEMBL15980407

COc1ccc(NC(C)=O)c(OC)c1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
TSHR P16473 1/20 0.51
HSD17B1 P14061 1/20 0.44
HSD17B2 P37059 1/20 0.44
ADORA2A P29274 1/20 0.44
ADORA2B P29275 1/20 0.44
ADORA1 P30542 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
ABCB1 P08183 1/20 0.44
POLB P06746 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
CYP1A2 P05177 2/20 0.41
NR3C1 P04150 1/20 0.41
PGR P06401 1/20 0.41
NR3C2 P08235 1/20 0.41
AR P10275 1/20 0.41
KDM4E B2RXH2 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24499182 0.81 ALDH1A1 (0.43) ALDH1A1TSHRMEN1KMT2AMAPT
SCHEMBL9023932 0.81 ALDH1A1 (0.53) ALDH1A1TSHRHSD17B1HSD17B2MEN1
SCHEMBL7291190 0.79 ALDH1A1 (0.50) ALDH1A1TSHRHSD17B1HSD17B2MEN1
SCHEMBL27775487 0.78 NR3C1 (0.51) ALDH1A1TSHRMEN1KMT2ANR3C1
SCHEMBL5409015 0.77 ALDH1A1 (0.59) ALDH1A1TSHRHSD17B1HSD17B2MEN1
SCHEMBL6774791 0.76 BRD4 (0.55) ALDH1A1TSHRADORA2AADORA2BMEN1
SCHEMBL11939269 0.75 RXFP1 (0.49) ALDH1A1TSHRHSD17B1HSD17B2MEN1
SCHEMBL31078153 0.75 ALDH1A1 (0.59) ALDH1A1TSHRADORA2AADORA2BADORA1
SCHEMBL29760424 0.75 ALDH1A1 (0.59) ALDH1A1TSHRHSD17B1HSD17B2ADORA2A
SCHEMBL4796147 0.75 ALDH1A1 (0.59) ALDH1A1TSHRHSD17B1HSD17B2ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9133129-B2 Bicyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-09-15 US disclosed
US-20140243310-A1 BICYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140243310-A1 BICYCLIC COMPOUND BICRA, NR3C2, CYP11B2 ALDH1A1 450/4885TSHR 4134/4885HSD17B1 93/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.